BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pathan T, Ingale S, Sharma A, Mohan R, Ramaa CS. Synthesis and preliminary evaluation of difluorinated 1,3-propanediones as potential agents in the treatment of breast cancer. Med Chem Res 2012;21:584-9. [DOI: 10.1007/s00044-011-9561-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Ming B, Gong G, Wang D, Bao G, Yu L. Current research on anti-breast cancer synthetic compounds. RSC Adv 2018;8:4386-416. [DOI: 10.1039/c7ra12912b] [Cited by in Crossref: 16] [Article Influence: 4.0] [Reference Citation Analysis]
2 Upadhyay N, Tilekar K, Loiodice F, Anisimova NY, Spirina TS, Sokolova DV, Smirnova GB, Choe JY, Meyer-Almes FJ, Pokrovsky VS, Lavecchia A, Ramaa CS. Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy. Bioorg Chem 2021;107:104527. [PMID: 33317839 DOI: 10.1016/j.bioorg.2020.104527] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Kabir A, Tilekar K, Upadhyay N, Ramaa C. Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines. ACAMC 2019;18:1551-62. [DOI: 10.2174/1871520618666180423111309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]